Next Article in Journal
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
Previous Article in Journal
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab
 
 
Article

Article Versions Notes

Cancers 2023, 15(17), 4273; https://doi.org/10.3390/cancers15174273
Action Date Notes Link
article xml file uploaded 26 August 2023 10:20 CEST Original file -
article xml uploaded. 26 August 2023 10:21 CEST Update https://www.mdpi.com/2072-6694/15/17/4273/xml
article pdf uploaded. 26 August 2023 10:21 CEST Version of Record https://www.mdpi.com/2072-6694/15/17/4273/pdf
article supplementary file uploaded. 26 August 2023 10:21 CEST - https://www.mdpi.com/2072-6694/15/17/4273#supplementary
article html file updated 26 August 2023 10:23 CEST Original file https://www.mdpi.com/2072-6694/15/17/4273/html
Back to TopTop